Totally, despite the significant improvement in noninvasive assessment of liver fibrosis with GLP‐1 RA treatment, their role of GLP‐1 RAs for fibrosis regression and for preventing liver fibrosis from developing into liver cirrhosis remains unclear. This evidence concerns the gene GCG and Hepatic fibrosis.